Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U7594AA | OT / LA |
they gave patient their dose of menquadfi and when pressing they thought that the expiration date was 30 mar2025 but it was 04mar2025 with no reported adverse event; Initial information received on 13-Mar-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 16 year old female patient who received Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] and when pressing they thought that the expiration date was 30-Mar-2025 but it was 04 Mar-2025 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Mar-2025, the patient received a 0.5ml dose of suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection standard strength, frequency-once, (lot U7594AA) (expiry date-04-Mar-2025) via intramuscular route in the left deltoid for Immunization and when pressing they thought that the expiration date was 30-Mar-2025 but it was 04 Mar-2025 with no reported adverse event (expired product administered). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.